跳到正文
原文
Nature 健康护理主题·· 9 天前AI 评分50

CAR T细胞和T细胞偶联剂在肾移植术前脱敏治疗中的应用

CAR T cells and T cell engagers for desensitization in kidney transplantation

AI 导读

文章综述了CAR T细胞和T细胞偶联剂在肾移植术前脱敏治疗中的应用前景,讨论了治疗风险与移植生存率和生活质量的关系。

正文
  • Clinical Outlook
  • Published: 11 November 2026

Nature Reviews Nephrology (2026) Cite this article

Chimeric antigen receptor (CAR) T cells and bispecific T cell engagers (TCEs) have potential as effective desensitization therapies in highly sensitized kidney transplant candidates. Clinical utility will depend on balancing treatment-related risks against the potential survival and quality-of-life benefits of facilitated transplantation.

This is a preview of subscription content, access via your institution

Access options

Access through your institution

Access Nature and 54 other Nature Portfolio journals

Get Nature+, our best-value online-access subscription

32.70 € / 30 days cancel any time

Learn more

Buy this article

  • Purchase on SpringerLink
  • Instant access to the full article PDF.

39,95 €

Prices may be subject to local taxes which are calculated during checkout

Additional access options:

Fig. 1: CAR T cells and TCEs and antigen targets for desensitization of highly sensitized kidney transplant candidates.

CAR T cells and bispecific T cell engagers, or TCEs, target B cells or plasma cells. CAR T cells bind CD19 on B cells or BCMA on plasma cells for targeted killing. TCEs connect CD3 on a T cell to CD19 on a B cell or BCMA on a plasma cell, leading to T cell activation and killing.

References

  1. Boenink, R. et al. The ERA Registry annual report 2022: epidemiology of kidney replacement therapy in Europe, with a focus on sex comparisons. Clin. Kidney J. 18, sfae405 https://doi.org/10.1093/ckj/sfae405 (2025).

    Article  PubMed  Google Scholar 

  2. Zecher, D. et al. Impact of sensitization on waiting time prior to kidney transplantation in Germany. Transplantation 106, 2448–2455 https://doi.org/10.1097/TP.0000000000004238 (2022).

    Article  PubMed  Google Scholar 

  3. Reuter, S., Lachmann, N., de Ferrante, H., Bohmig, G. A. & Budde, K. Highly sensitized kidney transplant candidates: integrating acceptable mismatch, desensitization, imlifidase, and emerging immune-cell targeting strategies. Front. Immunol. 17, 1868642 https://doi.org/10.3389/fimmu.2026.1868642 (2026).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Lorant, T. et al. Five years follow-up of imlifidase desensitized kidney transplant recipients. Transpl. Int. 38, 15425 https://doi.org/10.3389/ti.2025.15425 (2025).

    Article  PubMed  PubMed Central  Google Scholar 

  5. Tur, C. et al. CD19-CAR T-cell therapy induces deep tissue depletion of B cells. Ann. Rheum. Dis. 84, 106–114 https://doi.org/10.1136/ard-2024-226142 (2025).

    Article  CAS  PubMed  Google Scholar 

  6. Vandenboom, H. et al. Safety and efficacy of BCMA CAR-T vs. bispecific antibodies in patients with relapsed multiple myeloma: a systematic review and meta-analysis. Haematologica 111, 745–750 https://doi.org/10.3324/haematol.2025.288174 (2026).

    Article  PubMed  Google Scholar 

  7. Bhoj, V. G. et al. Kidney transplantation in two highly sensitized candidates after CAR T-cell therapy. N. Engl. J. Med. 394, 2117–2125 https://doi.org/10.1056/NEJMoa2513428 (2026).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Schrezenmeier, J. et al. Kidney transplantation after clearing anti-HLA antibodies with CD19 CAR T cells. N. Engl. J. Med. 394, 2166–2168 https://doi.org/10.1056/NEJMc2517277 (2026).

    Article  PubMed  Google Scholar 

  9. Leon, J. et al. B-cell maturation antigen-targeted T-cell engager therapy combined with B-cell depletion for treatment of refractory HLA sensitization. Kidney Int. 109, 1148–1154 https://doi.org/10.1016/j.kint.2026.01.020 (2026).

    Article  PubMed  Google Scholar 

  10. Schatzl, M. et al. T-cell engager-mediated HLA antibody depletion before kidney transplantation. N. Engl. J. Med. 395, 511–513 https://doi.org/10.1056/NEJMc2603853 (2026).

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Nephrology and Hypertension, Uniklinikum Erlangen and Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany

    Louisa Steines & Mario Schiffer

Authors

  1. Louisa Steines
  2. Mario Schiffer

Corresponding authors

Correspondence to Louisa Steines or Mario Schiffer.

Ethics declarations

Competing interests

The authors declare no competing interests.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Steines, L., Schiffer, M. CAR T cells and T cell engagers for desensitization in kidney transplantation. Nat Rev Nephrol (2026). https://doi.org/10.1038/s41581-026-01152-3

Download citation

  • Published: 11 November 2026

  • Version of record: 11 November 2026

  • DOI: https://doi.org/10.1038/s41581-026-01152-3

来源:Nature 健康护理主题 · nature.com